|
MYO19 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.027600E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.444200E-04 |
| Normal-vs-Stage2 |
1.148020E-02 |
| Normal-vs-Stage3 |
1.483250E-01 |
| Normal-vs-Stage4 |
1.073990E-01 |
| Stage1-vs-Stage2 |
3.703800E-01 |
| Stage1-vs-Stage3 |
1.113950E-01 |
| Stage1-vs-Stage4 |
3.940600E-01 |
| Stage2-vs-Stage3 |
1.003970E-01 |
| Stage2-vs-Stage4 |
8.900600E-01 |
| Stage3-vs-Stage4 |
2.677400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.550300E-04 |
| Normal-vs-AfricanAmerican |
5.836400E-03 |
| Normal-vs-Asian |
8.458000E-03 |
| Caucasian-vs-AfricanAmerican |
7.847800E-01 |
| Caucasian-vs-Asian |
4.904800E-01 |
| AfricanAmerican-vs-Asian |
4.951800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.81000000000809E-05 |
| Normal-vs-Female |
7.223500E-03 |
| Male-vs-Female |
3.996800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.308310E-02 |
| Normal-vs-Extreme_Weight |
1.014420E-02 |
| Normal-vs-Obese |
7.195500E-03 |
| Normal-vs-Extreme_Obese |
5.560100E-04 |
| Normal_Weight-vs-Extreme_Weight |
7.769600E-01 |
| Normal_Weight-vs-Obese |
9.070400E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.169600E-01 |
| Extreme_Weight-vs-Obese |
8.461400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.560500E-02 |
| Obese-vs-Extreme_Obese |
1.062650E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.79814999999861E-05 |
| Normal-vs-Age(41-60Yrs) |
6.370500E-04 |
| Normal-vs-Age(61-80Yrs) |
5.772000E-04 |
| Normal-vs-Age(81-100Yrs) |
7.692400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.288500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.001810E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.378900E-04 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.941000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.035510E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.100100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.6755000000509E-06 |
| Normal-VS-Type2 PRCC |
1.185010E-01 |
| Normal-VS-KIRP CIMP |
1.191890E-02 |
| Normal-VS-Unclassified PRCC |
4.141300E-03 |
| Type1 PRCC-VS-Type2 PRCC |
2.980800E-03 |
| Type1 PRCC-VS-KIRP CIMP |
9.498600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.662800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.163000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.115620E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.877400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.792400E-02 |
| Normal-vs-N1 |
6.331600E-02 |
| Normal-vs-N2 |
9.046600E-01 |
| N0-vs-N1 |
4.610200E-01 |
| N0-vs-N2 |
5.350800E-01 |
| N1-vs-N2 |
4.497600E-01 |
|
|
